Skip to main content
Equibles

Swiss National Bank

Bank

Position in PHAT — Phathom Pharmaceuticals, Inc.

CIK 1582202 ZURICH, V8
Back to PHAT Full portfolio

Position in PHAT

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,071,980
+$43,194 QoQ
Shares Held
98,800
+6.7% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 161 holders
Holding Since
Jun 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PHAT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. PHAT ranks #139 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in PHAT

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,071,980 98,800
2026-03-31 $1,028,786 92,600
2025-12-31 $1,393,560 84,000
2025-03-31 $459,591 73,300
2024-12-31 $595,196 73,300
2024-09-30 $1,325,264 73,300
2024-06-30 $576,800 56,000
2024-03-31 $594,720 56,000
2023-12-31 $511,280 56,000
2023-09-30 $624,274 60,200
2023-06-30 $1,023,880 71,500
2023-03-31 $288,456 40,400
2022-12-31 $465,630 41,500
2022-09-30 $459,820 41,500
2022-06-30 $350,260 41,500
2022-03-31 $454,574 33,400
2021-12-31 $609,770 31,000
2021-09-30 $995,100 31,000
2021-06-30 $1,049,350 31,000
2021-03-31 $623,496 16,600
2020-12-31 $534,842 16,100
2020-09-30 $590,387 16,100
2020-06-30 $529,851 16,100